Stock Details
LLY is Eli Lilly and Company's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 292.74$. Average daily volumn in 3 months 2.97M. Market cap 285.88B

Stock symbol : LLY. Exchange : NYSE. Currency : USD
Lastest price : 298.85$. Total volume : 3.13M. Market state POST
Click reload if you want to check the lastest price on market!!!

Eli Lilly and Company (LLY)
Last Price

Previous Close286.27
Day Range288.92-299.22
Bid299.20 x 1.1k
Ask299.50 x 1k
Average Volume2.97M
Market Cap285.88B
52 Week Range195.50-314.00
Trailing P/E45.63
Foward P/E39.90
Dividend (Yield %)1.34%
Ex-Dividend Date2022-05-13

Financial Details

According to Eli Lilly and Company's financial reports the company's revenue in 2021 were 28.32B an increase( +16.67%) over the years 2020 revenue that were of 24.54B. In 2021 the company's total earnings were 5.58B while total earnings in 2020 were 6.19B(-16.67%).

Loading ...


Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramz... a for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.


Market Cap:
Total Assets:
Total Cash:

News about "Eli Lilly and Company"


Eli Lilly announces $2.1 billion dollar expansion in Indiana

Source from : WFYI - 7 hours ago

Pharmaceutical company Eli Lilly announced a $2 billion expansion in Indiana during a press conference at the Governorโ€™s Mansion on Wednesday.See details»


Eli Lilly allocates $2.1 billion to expand production footprint in Indiana

Source from : Seeking Alpha - 12 hours ago

Eli Lilly (LLY) announced Wednesday that the company earmarked $2.1 billion to expand its production capacity in Indiana with plans to build two new manufacturing sites.The facilities ...See details»


Eli Lilly to invest $2.1 billion in Lebanon manufacturing sites

Source from : FOX59 News on - 12 hours ago

Eli Lilly and Company has announced it will be investing $2.1 billion in two new manufacturing sites at Indianaโ€™s LEAP Lebanon Innovation and Research District in Boone ...See details»


Lilly Endowment Inc Sells 118,856 Shares of Eli Lilly and Company (NYSE:LLY) Stock

Source from : Defense World - 1 days ago

Eli Lilly and Company (NYSE:LLY โ€“ Get Rating) major shareholder Lilly Endowment Inc sold 118,856 shares of the companyโ€™s stock in a transaction dated Monday, May 23rd. The shares were sold at an ...See details»


Why This FDA Approval Is a Game Changer for Eli Lilly

Source from : Nasdaq - 1 days ago

Eli Lilly is a top healthcare company that continually finds new ways to grow and create value for its investors. Revenue of $28.3 billion last year has steadily grown by 24% from ...See details»

Eli Lilly will build $2 billion plant in Boone County's new industrial park

Source from : YAHOO!News - 11 hours ago

Eli Lilly and Co. will invest $2 billion in Boone County and be the first company to build a new plant on land set aside by the state for an industrial park on Lebanon's north side. State officials ...See details»

Eli Lilly and Company (LLY) Management Presents at UBS Global Healthcare Conference (Transcript)

Source from : Seeking Alpha - 1 days ago

UBS Global Healthcare Conference May 24, 2022 08:30 AM ET Company Participants Mike Mason - President of Lilly Diabetes Conference Call ...See details»


What 7 Analyst Ratings Have To Say About Eli Lilly

Source from : Business Insider - 2 days ago

Eli Lilly (NYSE:LLY) has observed the following analyst ratings within the last quarter: In the last 3 months, 7 analysts have offered 12-month price targets for Eli Lilly. The company has an average ...See details»


Eli Lilly and Company to assist insulin production in Bangladesh

Source from : New Age - 15 hours ago

With the assistance of pharmaceutical company Eli Lilly and Company, US, world standard insulin will be made in the plant of Centeon Pharma Ltd, sister concern of International Agencies (Bd) Ltd, ...See details»


Why Eli Lilly Stock Climbed Today

Source from : Nasdaq - 9 days ago

10 stocks we like better than Eli Lilly and Company When our award-winning analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool ...See details»


Eli Lilly rallies on FDA approval of a diabetes drug that may also help with obesity

Source from : CNBC - 9 days ago

The FDA approved Lilly's new type 2 diabetes treatment Friday, helping give the pharmaceutical giant's stock a lift Monday.See details»


Here are Monday's biggest analyst calls: Gap, Eli Lilly, Nvidia, Ralph Lauren, Amazon & more

Source from : CNBC - 2 days ago

UBS reiterates Apple as buy UBS said that its survey checks show a "modest downtick" in iPhone demand. "Key takeaways from the survey pertaining to Apple are: 1) China iPhone purchase intent was up ...See details»


Eli Lillyโ€™s diabetes portfolio grows with FDA nod for projected blockbuster drug

Source from : MedCity News - 10 days ago

The FDA approved Eli Lily drug Mounjaro as a treatment for type 2 diabetes. The decision gives the pharmaceutical giant a new competitor to a blockbuster drug from rival Novo Nordisk, as well as a ...See details»

Why Eli Lilly Shares Are Rising Today

Source from : - 5 days ago

Eli Lilly And Co LLY shares are trading higher by 3.58% at $296.48 after the company announced the CHMP has issued a positive opinion for OLUMIANT for the treatment of adults with severe alopecia ...See details»